Background: The COVID-19 situation in Brazil is complex due to large differences in the shape and size of regional epidemics. Understanding these patterns is crucial to understand future outbreaks of SARS-CoV-2 or other respiratory pathogens in the country. Methods: We tested 97,950 blood donation samples for IgG antibodies from March 2020 to March 2021 in 8 of Brazil's most populous cities. Residential postal codes were used to obtain representative samples. Weekly age- and sex-specific seroprevalence were estimated by correcting the crude seroprevalence by test sensitivity, specificity, and antibody waning. Results: The inferred attack rate of SARS-CoV-2 in December 2020, before the Gamma variant of concern (VOC) was dominant, ranged from 19.3% (95% credible interval [CrI] 17.5-21.2%) in Curitiba to 75.0% (95% CrI 70.8-80.3%) in Manaus. Seroprevalence was consistently smaller in women and donors older than 55 years. The age-specific infection fatality rate (IFR) differed between cities and consistently increased with age. The infection hospitalisation rate increased significantly during the Gamma-dominated second wave in Manaus, suggesting increased morbidity of the Gamma VOC compared to previous variants circulating in Manaus. The higher disease penetrance associated with the health system's collapse increased the overall IFR by a minimum factor of 2.91 (95% CrI 2.43-3.53). Conclusions: These results highlight the utility of blood donor serosurveillance to track epidemic maturity and demonstrate demographic and spatial heterogeneity in SARS-CoV-2 spread. Funding: This work was supported by Itaú Unibanco 'Todos pela Saude' program; FAPESP (grants 18/14389-0, 2019/21585-0); Wellcome Trust and Royal Society Sir Henry Dale Fellowship 204311/Z/16/Z; the Gates Foundation (INV- 034540 and INV-034652); REDS-IV-P (grant HHSN268201100007I); the UK Medical Research Council (MR/S0195/1, MR/V038109/1); CAPES; CNPq (304714/2018-6); Fundação Faculdade de Medicina; Programa Inova Fiocruz-CE/Funcap - Edital 01/2020 Number: FIO-0167-00065.01.00/20 SPU N°06531047/2020; JBS - Fazer o bem faz bem.
Background: The COVID-19 situation in Brazil is complex due to large differences in the shape and size of regional epidemics. Understanding these patterns is crucial to understand future outbreaks of SARS-CoV-2 or other respiratory pathogens in the country. Methods: We tested 97,950 blood donation samples for IgG antibodies from March 2020 to March 2021 in 8 of Brazil's most populous cities. Residential postal codes were used to obtain representative samples. Weekly age- and sex-specific seroprevalence were estimated by correcting the crude seroprevalence by test sensitivity, specificity, and antibody waning. Results: The inferred attack rate of SARS-CoV-2 in December 2020, before the Gamma variant of concern (VOC) was dominant, ranged from 19.3% (95% credible interval [CrI] 17.5-21.2%) in Curitiba to 75.0% (95% CrI 70.8-80.3%) in Manaus. Seroprevalence was consistently smaller in women and donors older than 55 years. The age-specific infection fatality rate (IFR) differed between cities and consistently increased with age. The infection hospitalisation rate increased significantly during the Gamma-dominated second wave in Manaus, suggesting increased morbidity of the Gamma VOC compared to previous variants circulating in Manaus. The higher disease penetrance associated with the health system's collapse increased the overall IFR by a minimum factor of 2.91 (95% CrI 2.43-3.53). Conclusions: These results highlight the utility of blood donor serosurveillance to track epidemic maturity and demonstrate demographic and spatial heterogeneity in SARS-CoV-2 spread. Funding: This work was supported by Itaú Unibanco 'Todos pela Saude' program; FAPESP (grants 18/14389-0, 2019/21585-0); Wellcome Trust and Royal Society Sir Henry Dale Fellowship 204311/Z/16/Z; the Gates Foundation (INV- 034540 and INV-034652); REDS-IV-P (grant HHSN268201100007I); the UK Medical Research Council (MR/S0195/1, MR/V038109/1); CAPES; CNPq (304714/2018-6); Fundação Faculdade de Medicina; Programa Inova Fiocruz-CE/Funcap - Edital 01/2020 Number: FIO-0167-00065.01.00/20 SPU N°06531047/2020; JBS - Fazer o bem faz bem.
Authors: Carolina Lucas; Chantal B F Vogels; Inci Yildirim; Jessica E Rothman; Peiwen Lu; Valter Monteiro; Jeff R Gehlhausen; Melissa Campbell; Julio Silva; Alexandra Tabachnikova; Mario A Peña-Hernandez; M Catherine Muenker; Mallery I Breban; Joseph R Fauver; Subhasis Mohanty; Jiefang Huang; Albert C Shaw; Albert I Ko; Saad B Omer; Nathan D Grubaugh; Akiko Iwasaki Journal: Nature Date: 2021-10-11 Impact factor: 69.504
Authors: Renato Mendes Coutinho; Flavia Maria Darcie Marquitti; Leonardo Souto Ferreira; Marcelo Eduardo Borges; Rafael Lopes Paixão da Silva; Otavio Canton; Tatiana P Portella; Silas Poloni; Caroline Franco; Mateusz M Plucinski; Fernanda C Lessa; Antônio Augusto Moura da Silva; Roberto Andre Kraenkel; Maria Amélia de Sousa Mascena Veras; Paulo Inácio Prado Journal: Commun Med (Lond) Date: 2021-11-15
Authors: Kayoko Shioda; Max S Y Lau; Alicia N M Kraay; Kristin N Nelson; Aaron J Siegler; Patrick S Sullivan; Matthew H Collins; Joshua S Weitz; Benjamin A Lopman Journal: Epidemiology Date: 2021-07-01 Impact factor: 4.822
Authors: Mélodie Monod; Alexandra Blenkinsop; Xiaoyue Xi; Daniel Hebert; Sivan Bershan; Simon Tietze; Oliver Ratmann; Marc Baguelin; Valerie C Bradley; Yu Chen; Helen Coupland; Sarah Filippi; Jonathan Ish-Horowicz; Martin McManus; Thomas Mellan; Axel Gandy; Michael Hutchinson; H Juliette T Unwin; Sabine L van Elsland; Michaela A C Vollmer; Sebastian Weber; Harrison Zhu; Anne Bezancon; Neil M Ferguson; Swapnil Mishra; Seth Flaxman; Samir Bhatt Journal: Science Date: 2021-02-02 Impact factor: 47.728
Authors: Andreza Aruska de Souza Santos; Darlan da Silva Candido; William Marciel de Souza; Lewis Buss; Sabrina L Li; Rafael H M Pereira; Chieh-Hsi Wu; Ester C Sabino; Nuno R Faria Journal: Sci Data Date: 2021-03-04 Impact factor: 6.444
Authors: Sabrina L Li; Rafael H M Pereira; Carlos A Prete; Alexander E Zarebski; Lucas Emanuel; Pedro J H Alves; Pedro S Peixoto; Carlos K V Braga; Andreza Aruska de Souza Santos; William M de Souza; Rogerio J Barbosa; Lewis F Buss; Alfredo Mendrone; Cesar de Almeida-Neto; Suzete C Ferreira; Nanci A Salles; Izabel Marcilio; Chieh-Hsi Wu; Nelson Gouveia; Vitor H Nascimento; Ester C Sabino; Nuno R Faria; Jane P Messina Journal: BMJ Glob Health Date: 2021-04
Authors: Catherine J Reynolds; Corinna Pade; Joseph M Gibbons; Áine McKnight; Daniel M Altmann; Rosemary Boyton; David K Butler; Ashley D Otter; Katia Menacho; Marianna Fontana; Angelique Smit; Jane E Sackville-West; Teresa Cutino-Moguel; Mala K Maini; Benjamin Chain; Mahdad Noursadeghi; Tim Brooks; Amanda Semper; Charlotte Manisty; Thomas A Treibel; James C Moon; Ana M Valdes Journal: Science Date: 2021-04-30 Impact factor: 63.714
Authors: Clara Di Germanio; Graham Simmons; Kathleen Kelly; Rachel Martinelli; Orsolya Darst; Mahzad Azimpouran; Mars Stone; Kelsey Hazegh; Eduard Grebe; Shuting Zhang; Peijun Ma; Marek Orzechowski; James E Gomez; Jonathan Livny; Deborah T Hung; Ralph Vassallo; Michael P Busch; Larry J Dumont Journal: Transfusion Date: 2021-06-14 Impact factor: 3.157
Authors: Carlos A Prete; Lewis F Buss; Charles Whittaker; Tassila Salomon; Marcio K Oikawa; Rafael H M Pereira; Isabel C G Moura; Lucas Delerino; Manoel Barral-Netto; Natalia M Tavares; Rafael F O Franca; Viviane S Boaventura; Fabio Miyajima; Alfredo Mendrone-Junior; Cesar de Almeida-Neto; Nanci A Salles; Suzete C Ferreira; Karine A Fladzinski; Luana M de Souza; Luciane K Schier; Patricia M Inoue; Lilyane A Xabregas; Myuki A E Crispim; Nelson Fraiji; Fernando L V Araujo; Luciana M B Carlos; Veridiana Pessoa; Maisa A Ribeiro; Rosenvaldo E de Souza; Sônia M N da Silva; Anna F Cavalcante; Maria I B Valença; Maria V da Silva; Esther Lopes; Luiz A Filho; Sheila O G Mateos; Gabrielle T Nunes; Alexander L Silva-Junior; Michael P Busch; Marcia C Castro; Christopher Dye; Oliver Ratmann; Nuno R Faria; Vítor H Nascimento; Ester C Sabino Journal: Elife Date: 2022-09-22 Impact factor: 8.713